Warren Miller

460 total citations
7 papers, 351 citations indexed

About

Warren Miller is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Warren Miller has authored 7 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Warren Miller's work include Cancer therapeutics and mechanisms (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Warren Miller is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Warren Miller collaborates with scholars based in United Kingdom and New Zealand. Warren Miller's co-authors include Shouming Wang, John Milton, Nigel Vicker, Prakash Mistry, Peter Charlton, Stephen P. Wren, Adrian Folkes, Alistair Stewart, David Hardick and William A. Denny and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Chemischer Informationsdienst.

In The Last Decade

Warren Miller

7 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Warren Miller United Kingdom 6 211 167 56 53 46 7 351
Alain Pierré France 8 107 0.5× 270 1.6× 38 0.7× 53 1.0× 135 2.9× 15 406
Cherng-Chyi Tzeng Taiwan 10 273 1.3× 185 1.1× 64 1.1× 42 0.8× 36 0.8× 16 401
James D. Liddil United States 12 97 0.5× 253 1.5× 54 1.0× 26 0.5× 86 1.9× 19 427
Frederick Wong United States 11 179 0.8× 212 1.3× 11 0.2× 58 1.1× 53 1.2× 18 456
Ikuo Mitsui Japan 11 189 0.9× 311 1.9× 59 1.1× 51 1.0× 231 5.0× 17 517
Maria M. Bontemps‐Gracz Italy 11 199 0.9× 220 1.3× 72 1.3× 28 0.5× 103 2.2× 19 368
Ilse Gebhard United States 8 200 0.9× 283 1.7× 59 1.1× 70 1.3× 97 2.1× 8 400
Sukhjit Sohal United Kingdom 5 259 1.2× 139 0.8× 56 1.0× 41 0.8× 45 1.0× 5 363
Heba A. Hassan Egypt 14 387 1.8× 261 1.6× 22 0.4× 36 0.7× 94 2.0× 31 595
Anna I. Koutsourea Greece 13 226 1.1× 198 1.2× 32 0.6× 20 0.4× 66 1.4× 22 377

Countries citing papers authored by Warren Miller

Since Specialization
Citations

This map shows the geographic impact of Warren Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Miller more than expected).

Fields of papers citing papers by Warren Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Miller. The network helps show where Warren Miller may publish in the future.

Co-authorship network of co-authors of Warren Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Warren Miller. A scholar is included among the top collaborators of Warren Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren Miller. Warren Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bell, Kathryn M., Katie Ellard, Andrew D. Cansfield, et al.. (2012). SAR studies around a series of triazolopyridines as potent and selective PI3Kγ inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(16). 5257–5263. 35 indexed citations
2.
Wang, Shouming, Adrian Folkes, Irina Chuckowree, et al.. (2004). Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance. Journal of Medicinal Chemistry. 47(6). 1329–1338. 69 indexed citations
3.
Wang, Shouming, Warren Miller, John Milton, et al.. (2002). Structure–activity relationships for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576. Bioorganic & Medicinal Chemistry Letters. 12(3). 415–418. 49 indexed citations
4.
Wang, Shouming, Julian M.C. Golec, Warren Miller, et al.. (2002). Novel Inhibitors of Plasminogen Activator Inhibitor-1: Development of New Templates From Diketopiperazines. Bioorganic & Medicinal Chemistry Letters. 12(17). 2367–2370. 29 indexed citations
5.
Vicker, Nigel, Irina Chuckowree, Adrian Folkes, et al.. (2002). Novel Angular Benzophenazines:  Dual Topoisomerase I and Topoisomerase II Inhibitors as Potential Anticancer Agents. Journal of Medicinal Chemistry. 45(3). 721–739. 116 indexed citations
6.
Bundy, Gordon L., et al.. (1984). ChemInform Abstract: Synthesis and Platelet Aggregation Inhibiting Activity of Prostaglandin D Analogues.. Chemischer Informationsdienst. 15(8). 1 indexed citations
7.
Bundy, Gordon L., et al.. (1983). Synthesis and platelet aggregation inhibiting activity of prostaglandin D analogs. Journal of Medicinal Chemistry. 26(6). 790–799. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026